These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
332 related items for PubMed ID: 27483249
1. Peroxisome Proliferator-Activated Receptor γ Expression Is Inversely Associated with Macroscopic Vascular Invasion in Human Hepatocellular Carcinoma. Hsu HT, Sung MT, Lee CC, Kuo YJ, Chi CW, Lee HC, Hsia CY. Int J Mol Sci; 2016 Jul 29; 17(8):. PubMed ID: 27483249 [Abstract] [Full Text] [Related]
2. Activation of peroxisome proliferator-activated receptor-gamma inhibits tumor growth by negatively regulating nuclear factor-κB activation in patients with hepatocellular carcinoma. Nojima H, Kuboki S, Shinoda K, Shimizu H, Ohtsuka M, Kato A, Yoshitomi H, Furukawa K, Takayashiki T, Miyazaki M. J Hepatobiliary Pancreat Sci; 2016 Sep 29; 23(9):574-84. PubMed ID: 27451128 [Abstract] [Full Text] [Related]
3. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma. Kim KR, Choi HN, Lee HJ, Baek HA, Park HS, Jang KY, Chung MJ, Moon WS. Oncol Rep; 2007 Oct 29; 18(4):825-32. PubMed ID: 17786342 [Abstract] [Full Text] [Related]
4. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma. Zhang XF, Chao J, Pan QZ, Pan K, Weng DS, Wang QJ, Zhao JJ, He J, Liu Q, Jiang SS, Chen CL, Zhang HX, Xia JC. Oncotarget; 2015 Dec 01; 6(38):40920-33. PubMed ID: 26506518 [Abstract] [Full Text] [Related]
5. Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma. Wang W, Li GY, Zhu JY, Huang DB, Zhou HC, Zhong W, Ji CS. Med Oncol; 2015 Apr 01; 32(4):131. PubMed ID: 25796501 [Abstract] [Full Text] [Related]
6. High expression of TRIM44 is associated with enhanced cell proliferation, migration, invasion, and resistance to doxorubicin in hepatocellular carcinoma. Zhu X, Wu Y, Miao X, Li C, Yin H, Yang S, Lu X, Liu Y, Chen Y, Shen R, Chen X, He S. Tumour Biol; 2016 Nov 01; 37(11):14615-14628. PubMed ID: 27619678 [Abstract] [Full Text] [Related]
7. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity. Wu XS, Bao TH, Ke Y, Sun DY, Shi ZT, Tang HR, Wang L. Tumour Biol; 2016 Nov 01; 37(11):14711-14719. PubMed ID: 27623945 [Abstract] [Full Text] [Related]
8. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression. Tu K, Dou C, Zheng X, Li C, Yang W, Yao Y, Liu Q. BMC Cancer; 2014 Dec 12; 14():938. PubMed ID: 25494879 [Abstract] [Full Text] [Related]
9. Peroxisome proliferator-activated receptor-γ activation inhibits hepatocellular carcinoma cell invasion by upregulating plasminogen activator inhibitor-1. Pang X, Wei Y, Zhang Y, Zhang M, Lu Y, Shen P. Cancer Sci; 2013 Jun 12; 104(6):672-80. PubMed ID: 23461356 [Abstract] [Full Text] [Related]
10. [The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma]. Xu Q, Cai W, Zhang M, Liu Q, Liu X. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar 12; 32(3):387-92. PubMed ID: 26927562 [Abstract] [Full Text] [Related]
11. Activation of peroxisome proliferator-activated receptor-γ (PPARγ) inhibits hepatoma cell growth via downregulation of SEPT2 expression. Cao LQ, Shao ZL, Liang HH, Zhang DW, Yang XW, Jiang XF, Xue P. Cancer Lett; 2015 Apr 01; 359(1):127-35. PubMed ID: 25592041 [Abstract] [Full Text] [Related]
12. Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptor{gamma} ligands in vitro and in vivo. Hsu MC, Huang CC, Chang HC, Hu TH, Hung WC. Clin Cancer Res; 2008 Jul 01; 14(13):4045-52. PubMed ID: 18593980 [Abstract] [Full Text] [Related]
13. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma. Lei X, Li YF, Chen GD, Ou DP, Qiu XX, Zuo CH, Yang LY. Oncotarget; 2015 Dec 01; 6(38):40622-41. PubMed ID: 26536663 [Abstract] [Full Text] [Related]
14. Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma. Chen W, Chen L, Cai Z, Liang D, Zhao B, Zeng Y, Liu X, Liu J. Tumour Biol; 2016 Jul 01; 37(7):9343-55. PubMed ID: 26779633 [Abstract] [Full Text] [Related]
15. Downregulation of paraoxonase 3 contributes to aggressive human hepatocellular carcinoma progression and associates with poor prognosis. Jin Y, Li Q, Qiu J, Zhao X, Zheng C, Lv S, Bai Y, Shan Y, Ye LC. Tumour Biol; 2016 Oct 01; 37(10):14193-14203. PubMed ID: 27553024 [Abstract] [Full Text] [Related]
16. High Expression of Neuropilin-1 Associates with Unfavorable Clinicopathological Features in Hepatocellular Carcinoma. Zhang Y, Liu P, Jiang Y, Dou X, Yan J, Ma C, Fan Q, Wang W, Su F, Tang H, Su X. Pathol Oncol Res; 2016 Apr 01; 22(2):367-75. PubMed ID: 26563279 [Abstract] [Full Text] [Related]
17. Ribosomal protein S15a promotes tumor angiogenesis via enhancing Wnt/β-catenin-induced FGF18 expression in hepatocellular carcinoma. Guo P, Wang Y, Dai C, Tao C, Wu F, Xie X, Yu H, Zhu Q, Li J, Ye L, Yu F, Shan Y, Yu Z, Dhanasekaran R, Zheng R, Chen G. Oncogene; 2018 Mar 01; 37(9):1220-1236. PubMed ID: 29242604 [Abstract] [Full Text] [Related]
18. Pigment epithelium-derived factor is an angiogenesis and lipid regulator that activates peroxisome proliferator-activated receptor alpha. Chung C, Doll JA, Stellmach VM, Gonzales J, Surapureddi S, Cornwell M, Reddy JK, Crawford SE. Adv Exp Med Biol; 2008 Mar 01; 617():591-7. PubMed ID: 18497086 [Abstract] [Full Text] [Related]
19. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F. Luo G, Chao YL, Tang B, Li BS, Xiao YF, Xie R, Wang SM, Wu YY, Dong H, Liu XD, Yang SM. Oncotarget; 2015 Nov 10; 6(35):37808-23. PubMed ID: 26498692 [Abstract] [Full Text] [Related]
20. Overexpression of interleukin-32α promotes invasion by modulating VEGF in hepatocellular carcinoma. Zhao WB, Wang QL, Xu YT, Xu SF, Qiu Y, Zhu F. Oncol Rep; 2018 Mar 10; 39(3):1155-1162. PubMed ID: 29286122 [Abstract] [Full Text] [Related] Page: [Next] [New Search]